Results of immunochemotherapy with interleukin-2, interferon-α2 and 5-fluorouracil in the treatment of metastatic renal cell cancer

European Urology

Volumn 35, Issue 3, 1999, Pages 204-209

  Samland, D ^a   Steinbach, F ^a   Reiher, F ^a   Schmidt, U ^a   Gruss, A ^a   Allhoff, E P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Fluorouracil; Interferon ; Interleukin 2; Kidney neoplasms; Renal cell carcinoma

Indexed keywords

FLUOROURACIL; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; ANEMIA; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CHILL; CLINICAL ARTICLE; DERMATITIS; DIARRHEA; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; LEUKOPENIA; MALAISE; MALE; METASTASIS; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

EID: 0033007699     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000019847     Document Type: Article

References (18)